+1 (855) PLE.XISION (753.9474) info@plexision.com


You are here

Predicting cytomegalovirus viremia….with CMV-specific T-cells

Predicting cytomegalovirus viremia after liver or intestine transplantation (LTx, ITx) with CMV-specific T-cell subsets

Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children

Allospecific CD154+T-cytotoxic memory cells (CD154+TcM) predict acute cellular rejection after liver transplantation (LTx) or intestine transplantation (ITx) in small cohorts of children and can enhance immunosuppression management, but await validation and clinical implementation.
To establish safety and probable benefit, CD154+TcM were measured in cryopreserved samples from 214 children younger than 21 years (National Clinical Trial 1163578).

Prognostic cell-based assay predicts acute cellular rejection in pre- and post-transplant testing of children with liver and intestine transplantation (LTx, ITx).

Below is an extract of the original abstract from the Liver Meeting help in Washington DC.© The American Association for the Study of Liver Diseases. Original abstracts could be accessed via their site here